Relvar Ellipta 92/22 (Fluticasone furoate + vilanterol Inhaler) 92mcg/22mcg x 30doses

Relvar Ellipta 92/22 is an inhaled corticosteroid and long-acting beta2-agonist combination used for asthma and COPD maintenance. This inhaler delivers 92mcg fluticasone furoate and 22mcg vilanterol per dose. Find reliable respiratory care with convenient once-daily dosing.

Strength

92mcg/22mcg x 30doses

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Glaxosmithkline

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Relvar Ellipta 92/22 is used to control and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). It helps reduce inflammation in the airways and keeps breathing passages open for easier airflow. This medication is intended for maintenance therapy rather than quick relief of sudden breathing problems. It works best when used regularly as prescribed by a healthcare provider.

Side Effects

Users may experience improved breathing comfort and reduced wheezing or shortness of breath over time. Some people notice a decrease in coughing and chest tightness with regular use. The inhaler is designed for once-daily use, which can support consistent symptom management. Individual responses may vary based on condition and adherence.

Precautions & Warnings

Store the inhaler at room temperature away from moisture and direct heat. Keep the device sealed until ready to use and discard after the labeled number of doses. Rinse your mouth with water after each use to help reduce the risk of oral infections. Always check the dose counter to ensure you have remaining inhalations.

Avoid Interactions

Certain medications may affect how Relvar Ellipta works, including strong CYP3A4 inhibitors like ketoconazole or ritonavir. Beta-blockers, such as propranolol, may reduce the effectiveness of vilanterol. Discuss all current medications with your healthcare provider before starting this inhaler. Avoid using other long-acting bronchodilators unless directed.

Frequently Asked Questions

It is used for long-term control of asthma and COPD symptoms as part of maintenance therapy.

Follow the instructions provided with the device; it is a breath-activated inhaler used once daily.

Do not stop using it without consulting your healthcare provider, as sudden discontinuation may worsen symptoms.

Common effects may include headache, throat irritation, or oral thrush; rinse mouth after use to reduce risk.

No, it is not intended for sudden breathing problems; use a short-acting inhaler for acute symptoms.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.